Because of crosstalk between Src and EGFR, it has been hypothesized that the suppression of Src and its downstream signaling partners may induce apoptosis [41] and overcome gefitinib resistance [38] in lung cancer cells. This evidence concerns the gene SRC and lung carcinoma.